AXIL earnings analysis
What we found in AXIL's 10-K: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
AXIL delivered strong fiscal 2026 growth, with revenue up 17.5% to $30.8 million and diluted EPS rising to $0.33, driven by rapid expansion of hearing products into big-box and specialty retail. The strategy is increasingly centered on retail distribution, product innovation and a new marketing-services platform, but the channel shift reduced gross margin to 69.3% and operating cash flow turned slightly negative because of year-end working-capital investment. Customer and supplier concentration, tariff exposure and the declining hair-and-skin-care segment temper the otherwise positive earnings trajectory.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Retail expansion drove strong earnings growth
- Fiscal 2026 revenue increased 17.5% to $30,847,570 from $26,257,522, primarily driven by big-box retail orders in hearing enhancement and protection. Operating income rose 156.3% to $2,977,043 from $1,161,365, while diluted EPS increased to $0.33 from $0.10.
- Broader mass, specialty and military reach
- AXIL expanded distribution through approximately 1,250 Walmart stores for MX PRO and MX Passive models, approximately 70 Sportsman's Warehouse locations and e-commerce, and expects its full product line at U.S. Marine Corps Exchange locations beginning in fiscal Q1 2027.
- Product portfolio expanded across form factors
- The product roadmap added the MX II Series using proprietary SonicShieldX technology, with MX II PRO deliveries beginning in February 2026, additional variants released in May 2026, and AXIL CRX becoming available in May 2026.
- Wholesale channel is scaling rapidly
- Hearing enhancement and protection retail and wholesale revenue grew 136.9% to $9,862,759 and increased to 33.4% of segment revenue from 16.8%; segment non-cash operating income increased 54.8% to $5,437,769.
- Adjusted profitability improved materially
- Adjusted EBITDA increased 66.2% to $4,039,411, and adjusted EBITDA margin improved to 13.1% from 9.3%. The improvement reflects higher big-box retail volume despite increased operating expenses.
- Debt eliminated and tariff cash recovered
- The Company repaid its $140,229 EIDL balance in full and had no outstanding borrowings at May 31, 2026. It also received approximately $910,000 of IEEPA duty refunds after year-end, including interest, to be reflected in fiscal 2027 cash flows.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Material dependence on one customer
- Customer concentration materially increased: one hearing segment customer represented 24% of segment sales and 23% of consolidated revenue in fiscal 2026, versus no customer above 10% in fiscal 2025; the customer also represented 69% of segment accounts receivable at May 31, 2026.
- Mix shift is compressing gross margins
- Retail and wholesale revenue rose to approximately 35% of consolidated revenue from approximately 21%, but this channel carries lower gross margins and drove consolidated gross margin down to 69.3% from 71.0%. Management expects continued channel growth may place additional downward pressure on gross margin.
- Working capital absorbs operating cash
- Operating cash flow swung to negative $9,635 from positive $1,928,661, as year-end big-box orders increased accounts receivable by $3,824,562 and inventory by $1,885,970. Inventory reached $4,419,628 versus $2,533,658, while non-cancellable inventory purchase commitments were approximately $1,080,000.
- Tariff exposure remains elevated
- The Company paid approximately $900,000 in IEEPA duties during fiscal 2026 and now faces new tariff rates generally ranging from 10% to 12.5% on most imports from certain countries; future tariff changes could increase landed costs and compress margins.
- Supplier concentration increased
- The largest supplier accounted for 79% of purchases related to hearing enhancement and protection products in fiscal 2026, compared with the two largest suppliers representing 67% and 23% in fiscal 2025, increasing dependence on a single vendor.
- Reviv3 relaunch execution risk
- The hair and skin care segment declined 21.9% to $1,188,996 and moved to a $47,611 segment non-cash operating loss. The planned Reviv3 relaunch is scheduled for September 2026, but the timing and volume of resulting distributor and retailer orders remain uncertain.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.33
- Gross margin
- 69.3%
- Operating margin
- 9.7%
- Segment
- Hearing enhancement and protection: $29,558,574 revenue, up 19.5% and approximately 96% of consolidated revenue; segment non-cash operating income $5,437,769.
- Segment
- Hair and skin care: $1,188,996 revenue, down 21.9% and approximately 4% of consolidated revenue; segment non-cash operating loss of $47,611.
- Segment
- Marketing services: $100,000 revenue and $91,492 segment non-cash operating income, representing less than 1% of consolidated revenue.
What they said about what is next.
No numeric revenue or EPS guidance was provided. Management stated that it expects to continue generating net income and positive cash flow in fiscal 2027, but provided no assurance; it also expects additional Reviv3 distributors and retailers following the September 2026 relaunch, with timing and order volumes uncertain.
The filing reads about the same as the one before it.
What came before.
- 10-Q · April 8, 2026
- AXIL reported quarterly revenue of $7,294,030 (up $371,663 vs. prior-year quarter) but showed margin compression and EPS decline. Gross profit was $5,041,821 (gross margin ~69.1%), operating income fell to $214,239…
- 10-Q · January 8, 2025
- AXIL reported quarterly sales of $7,732,574 and diluted EPS of $0.08 for the three months ended November 30, 2024. Revenue and gross profit declined versus the prior-year quarter, but operating cash flow was strong at…
- 10-Q · October 10, 2024
- AXIL reported sales of $5,851,272 and a net loss of $109,805 (diluted EPS $(0.02)) for the three months ended August 31, 2024. Operating cash flow was strong at $897,318 and cash ended the period at $4,148,724, but…
- 10-K · August 21, 2023
- Reviv3 Procare completed the AXIL acquisition (June 16, 2022) and shifted its primary focus to hearing enhancement and protection, which accounted for 93.0% of revenue for the fiscal year ended May 31, 2023. The…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing AXIL makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever